search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
COVER STORY


with an additional cost or reduced quality. This perception is something Tecman is passionate about changing. Like every product in its portfolio, Optec is underpinned by ‘Four Pillars of Comfort’:


Comfort – ergonomically designed for optimal all day comfort using skin friendly,


medical grade materials


Performance - Optec is equally effective at providing protection from spray and droplets as single- use products and is fully EN 166:2001 certified when using the impact resistant screen.


Sustainability – Optec makes use of reusable bioplastic made from trees, is more compact and more


effectively shipped


Cost - Optec and all Tecman products are cost competitive with imported alternatives,


breaking the perceived link between quality and cost. NHS organisations no longer have to choose between budget, staff protection and protecting the planet.


Optec provides procurement professionals with a choice that meets both organisation-


wide carbon reduction goals and departmental/product cost constraints. Product quality plays a significant role in ensuring efficiencies within the NHS PPE supply chain. As Tecman products are quality managed and manufactured in the UK through an established quality management system, the company has a 100% product quality record with no faulty or subpar products reported, either by end users within the NHS, or from medical distribution partners. By supplying quality face and eye protection with guaranteed performance, Tecman strives to support efficiencies within its customers’ supply chains, helping to reduce the additional costs and resources associated with handling subpar products.


This has never been more relevant than during the peak of the COVID-19 pandemic, with containers of imported subpar or faulty product contributing to the critical situation of PPE availability. Supply chain security from trusted manufacturers and suppliers became a front and central topic and highlighted how critical supply efficiencies are. Tecman are passionate about playing a leading role in ensuring the UK has the capability to provide critical protective equipment to the NHS, both now and into the future, so key workers do not face the same desperate situation again.


About Tecman


Tecman Advanced Healthcare Products is a leading UK manufacturer of face and eye protection. Founded in 2020 to address the critical shortage of PPE for NHS workers, the company is now recognised within the healthcare sector as a trusted manufacturer of certified face and eye protection products. Tecman currently exports throughout Europe, working with global organisations such as UNICEF and the World Health Organization (WHO) to ensure production remains at peak levels. Central to Tecman’s ethos and product innovation is a powerful R&D programme which directly resulted in the development of the Optec™ bioplastic. Through this continuous investment in next generation biomaterials, including bioplastics and plastic free filtration technology, Tecman are investing in the future of face and eye protection. Tecman’s long-term commitment is to help change the landscape of sustainable materials by reinvesting a significant percentage of profit back into the development of tomorrow’s biomaterials. It’s Tecman’s vision to not only replace plastic within their own product lines, but to also make these sustainable materials affordable and efficient to use beyond their own products and industry.


Tecman Advanced Healthcare Products Ltd Berrington House, Berrington Road Leamington Spa, Warwickshire CV31 1NB, UK 01926 337466 sales@tecmanuk.com www.tecmanuk.com/healthcare-products/


AUGUST 2021 WWW.CLINICALSERVICESJOURNAL.COM l 59


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88